2H-1,5-Benzodioxepin-3(4H)-one, 7-methyl-
Common Name: |
2H-1,5-Benzodioxepin-3(4H)-one, 7-methyl- |
IUPAC Name: |
7-methyl-1,5-benzodioxepin-3-one |
Molecular Formula: |
C10H10O3 |
SMILES: |
CC1=CC2=C(C=C1)OCC(=O)CO2 |
Inchi: |
1S/C10H10O3/c1-7-2-3-9-10(4-7)13-6-8(11)5-12-9/h2-4H,5-6H2,1H3 |
Inchi Key: |
SWUIQEBPZIHZQS-UHFFFAOYSA-N |
Cas No: |
28940-11-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
178.18 |
Mass (g/mol) |
178.063 |
Molar Refractivity |
47.28 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
0 |
Rings |
2 |
TPSA |
35.53 |
Hetero Atoms |
3 |
Heavy Atoms |
13 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
38.00 to 41.00 |
Boiling Point (°C@760.00mm Hg) |
158.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.001 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.30 |
LogP |
1.335 |
iLOGP |
1.94 |
XLOGP3 |
1.88 |
WLOGP |
1.34 |
MLOGP |
0.74 |
ESOL Log S |
-2.47 |
ESOL Solubility (mg/ml) |
0.603 |
ESOL Solubility (mol/l) |
0.003 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.25 |
Ali Solubility (mg/ml) |
1.01 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.98 |
Silicos-IT Solubility (mg/ml) |
0.19 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.05 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.807 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.363 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |